Prestige Consumer Healthcare
PBH
#3940
Rank
$2.99 B
Marketcap
$60.82
Share price
1.27%
Change (1 day)
-27.88%
Change (1 year)

EPS for Prestige Consumer Healthcare (PBH)

EPS in 2025 (TTM): $4.06

According to Prestige Consumer Healthcare's latest financial reports the company's current EPS (TTM) is $4.06. In 2024 the company made an earnings per share (EPS) of $4.30 an increase over its 2023 EPS that were of -$1.61.

EPS history for Prestige Consumer Healthcare from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)$4.06-5.58%
2024$4.30-367.08%
2023-$1.61-138.33%
2022$4.2011.7%
2021$3.7613.6%
2020$3.31-651.67%
2019-$0.60-148.78%
2018$1.23-83.29%
2017$7.36437.23%
2016$1.37-34.13%
2015$2.0852.94%
2014$1.36-8.11%
2013$1.48
2011$0.87

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
GlaxoSmithKline
GSK
$3.60-11.43%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
$1.72-57.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Rite Aid
RAD
-$29.62-829.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
$10.44 157.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Taro Pharmaceutical
TARO
$1.22-69.95%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Novartis
NVS
$7.36 81.28%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Procter & Gamble
PG
$7.03 73.15%๐Ÿ‡บ๐Ÿ‡ธ USA
CVS Health
CVS
$0.40-90.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Clorox
CLX
$6.41 57.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
$8.06 98.45%๐Ÿ‡บ๐Ÿ‡ธ USA